MRI with and without contrast showed a heterogeneous modest breakdown of the blood-tumor barrier in U87-CXCR4 intracranial xenografts (Fig. 5b), whereas little or no breakdown of the blood-tumor barrier was observed in intracranial PCNSL-15 tumors (Fig. 6a). Here, CXCR4 is linked to neoplasm.